| Financial Year |
March 31 2023 |
| Monetary Funds |
144,093,030.78 |
| Held-for-trading Financial Assets |
4,500,000.00 |
| Notes Receivable |
1,849,736.37 |
| Accounts Receivable |
594,158,092.62 |
| Advances to Suppliers |
43,265,287.43 |
| Other Receivables |
23,329,929.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
156,733,023.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,906,778.08 |
| Total Current Assets |
1,072,209,472.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
63,778,733.51 |
| Investment Properties |
-- |
| Fixed Assetes |
505,775,811.32 |
| Under-construction Projects |
146,609,398.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,738,513.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,980,910.95 |
| Deferred Income Tax Assets |
79,880,468.45 |
| Other Non-Current Assets |
587,170,443.71 |
| Sub-Total of Non-Current Assets |
1,506,015,796.90 |
| Total Assets |
2,578,225,269.47 |
| Short-Term Loans |
400,343,012.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
63,879,559.53 |
| Accounts Payable |
295,715,264.36 |
| Accounts Received In Advance |
54,931.45 |
| Employee Compensation Payable |
11,608,013.27 |
| Taxes Payable |
27,699,978.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,041,819.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,789,449.29 |
| Other Current Liabilities |
397,121.14 |
| Sub-Total of Current Liabilities |
870,538,023.89 |
| Long-term Loans |
66,008,342.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
148,264,288.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
428,812.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
275,622,886.20 |
| Total Liabilities |
1,146,160,910.09 |
| Paid-In Capital(Or Share Stock) |
720,034,264.00 |
| Capital Surplus |
587,393,739.99 |
| Surplus Reserve |
37,311,929.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-182,927,696.88 |
| Minority Stockholder's Interest |
279,955,172.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,152,109,186.94 |
| Owner's Equity（Stockholder's Equity） |
1,432,064,359.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,578,225,269.47 |
